We're in the business of helping you make human connections.
ICU Medical has consistently provided you with clinical innovations that help solve real-world challenges.
With the acquisition of Hospira Infusion Systems in 2017 and Smiths Medical in 2022, we are now a global market leader with a complete line of clinically-essential IV therapy and high-value critical care products for hospital, alternate site, and home care settings.
We're ready to bring you consistent quality, innovation, and value in more areas than ever.
100% committed to meeting your clinical needs. Now and in the future.
At ICU Medical, we're committed to controlling our quality from product concept, design, development, and testing—to manufacturing, sterilization, and distribution. Everything we do is focused on providing you with the highest quality products, service, and support.